ArticleScientific reports2026
Skin lesions associated with chronic exposure to arsenic in drinking water in rural Western Iran.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic exposure to arsenic through drinking water is a major public health concern and is associated with a wide range of adverse health effects, including dermatological lesions, cardiovascular disorders, and increased cancer risk. In this cross-sectional study, the prevalence of arsenic-related skin problems, i.e., hyperpigmentation and keratosis, in relation to arsenic level in drinking water in rural regions in northwest Hamadan Province, Iran, was investigated. Arsenic levels in drinking water during 2022–2023 were obtained from the Hamadan University of Medical Sciences Health Department. Three villages with arsenic levels above 50 µg/L in Kabudarahang County were selected as exposure sites, and two villages with low arsenic levels (< 2 µg/L) were selected as controls. 189 individuals from the exposed village residents and 223 from control village residents were interviewed with medical screenings. Demographic and health-related variables, including age, BMI, blood pressure, and skin lesion history, were recorded. Skin symptoms were significantly more prevalent among the exposure group: keratosis (adjusted OR = 10.18, 95% CI: 1.28–80.75, p = 0.028), hyperpigmentation (adjusted OR 3.94, 95% CI 1.05–14.67, p = 0.041), and other cutaneous complications (adjusted OR 5.05, 95% CI 1.66–15.33, p = 0.004). Age was a risk factor per se with each additional year having a 2–4% increased risk of skin lesions. Systolic blood pressure differed between groups (p < 0.001), suggesting possible interactions with cutaneous manifestations. Arsenic in drinking water at high levels has strong association with elevated prevalence of skin lesions, and therefore a requirement for systematic waters monitoring and mitigation processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.